{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:28:52Z","timestamp":1790022532742,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100591"],"award-info":[{"award-number":["82100591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2017-24-2110"],"award-info":[{"award-number":["Z-2017-24-2110"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpba.2024.116424","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:46:32Z","timestamp":1723722392000},"page":"116424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prediction of early remission after infliximab in Crohn\u2019s disease using baseline microbiome and metabolomics"],"prefix":"10.1016","volume":"251","author":[{"given":"Yanzhe","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeqian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpba.2024.116424_bib1","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000128","article-title":"Treatment pathways leading to biologic therapies for ulcerative colitis and Crohn's disease in the United States","volume":"11","author":"Siegel","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"12","key":"10.1016\/j.jpba.2024.116424_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/apt.12749","article-title":"Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease","volume":"39","author":"Stidham","year":"2014","journal-title":"Aliment Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.jpba.2024.116424_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/1751-2980.13025","article-title":"Quantifying the rate of recurrence of postoperative Crohn's disease with biological therapy. A meta-analysis","volume":"22","author":"Jain","year":"2021","journal-title":"J. Dig. Dis."},{"issue":"11-12","key":"10.1016\/j.jpba.2024.116424_bib4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/apt.15033","article-title":"Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease-personalised medicine in its infancy","volume":"48","author":"Stevens","year":"2018","journal-title":"Aliment Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jpba.2024.116424_bib5","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1111\/j.1572-0241.2002.05991.x","article-title":"Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease","volume":"97","author":"Vermeire","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116424_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2013.08.026","article-title":"Inflammatory bowel disease, phenotypic features of Crohn's disease associated with failure of medical treatment.","volume":"12","author":"Moran","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jpba.2024.116424_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/apt.13671","article-title":"The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-alpha naive Crohn's disease","volume":"44","author":"Narula","year":"2016","journal-title":"Aliment Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.jpba.2024.116424_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1365-2036.2012.05100.x","article-title":"Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study","volume":"35","author":"Zorzi","year":"2012","journal-title":"Aliment Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jpba.2024.116424_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000253855","article-title":"Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease","volume":"81","author":"Nichita","year":"2010","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.jpba.2024.116424_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.2002.35390","article-title":"Predictors of response to infliximab in patients with Crohn's disease","volume":"123","author":"Parsi","year":"2002","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jpba.2024.116424_bib11","first-page":"940","article-title":"[IL-17 and IL23 expression as a predictor of response to infliximab treatment in Crohn's disease].","volume":"54","author":"Zhang","year":"2015","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.jpba.2024.116424_bib12","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101088RRR","article-title":"Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease","volume":"36","author":"Feng","year":"2022","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.jpba.2024.116424_bib13","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1038\/s41467-020-17956-1","article-title":"Integrated microbiota and metabolite profiles link Crohn's disease to sulfur metabolism","volume":"11","author":"Metwaly","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2024.116424_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.606298","article-title":"Gut microbiota and metabolic specificity in ulcerative colitis and Crohn's disease","volume":"7","author":"Sankarasubramanian","year":"2020","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.jpba.2024.116424_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00009-15","article-title":"Improved bacterial 16S rRNA gene (V4 and V4-5) and fungal internal transcribed spacer marker gene primers for microbial community surveys","volume":"1","author":"Walters","year":"2016","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.jpba.2024.116424_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nprot.2012.135","article-title":"Global metabolic profiling of animal and human tissues via UPLC-MS","volume":"8","author":"Want","year":"2013","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.jpba.2024.116424_bib17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","article-title":"Predictors of primary response to biologic treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice","volume":"14","author":"Gisbert","year":"2020","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"10.1016\/j.jpba.2024.116424_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030687","article-title":"Changes in the intestinal microbiota are seen following treatment with infliximab in children with Crohn's disease","volume":"9","author":"Kowalska-Duplaga","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jpba.2024.116424_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13073-016-0331-y","article-title":"Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease","volume":"8","author":"Shaw","year":"2016","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.jpba.2024.116424_bib20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ibd\/izaa253","article-title":"Fecal microbiota alterations associated with clinical and endoscopic response to infliximab therapy in Crohn's disease","volume":"26","author":"Zhuang","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.jpba.2024.116424_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040697","article-title":"The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases","volume":"9","author":"Baldelli","year":"2021","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.jpba.2024.116424_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.jpba.2024.116424_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcmgh.2022.11.005","article-title":"Klebsiella pneumoniae induces inflammatory bowel disease through caspase-11-mediated IL18 in the gut epithelial cells","volume":"15","author":"Zhang","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jpba.2024.116424_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00730-21","article-title":"Akkermansia muciniphila alleviates dextran sulfate sodium (DSS)-induced acute colitis by NLRP3 activation","volume":"9","author":"Qu","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.jpba.2024.116424_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.jpba.2024.116424_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10123-023-00324-6","article-title":"Variation of butyrate production in the gut microbiome in type 2 diabetes patients","volume":"26","author":"Siptroth","year":"2023","journal-title":"Int. Microbiol."},{"issue":"10","key":"10.1016\/j.jpba.2024.116424_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12100895","article-title":"Histamine: a mediator of intestinal disorders-a review","volume":"12","author":"Smolinska","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2024.116424_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpeds.2016.01.003","article-title":"Increases in sex hormones during anti-tumor necrosis factor alpha therapy in adolescents with Crohn's disease","volume":"171","author":"DeBoer","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jpba.2024.116424_bib29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1749-6632.2000.tb05459.x","article-title":"Steroid hormone regulation of antiviral immunity","volume":"917","author":"Padgett","year":"2000","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2024.116424_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13880209.2019.1577461","article-title":"beta-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice","volume":"57","author":"Liu","year":"2019","journal-title":"Pharm. Biol."},{"issue":"4","key":"10.1016\/j.jpba.2024.116424_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/medicines3040029","article-title":"Critical analysis on characterization, systemic effect, and therapeutic potential of beta-sitosterol: a plant-derived orphan phytosterol","volume":"3","author":"Bin Sayeed","year":"2016","journal-title":"Medicines"},{"issue":"11","key":"10.1016\/j.jpba.2024.116424_bib32","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/ibd\/izac094","article-title":"Sex-related differences in inflammatory bowel diseases: the potential role of sex hormones","volume":"28","author":"Xu","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"issue":"11","key":"10.1016\/j.jpba.2024.116424_bib33","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1398-9995.2008.01880.x","article-title":"Gender difference, sex hormones, and immediate type hypersensitivity reactions","volume":"63","author":"Chen","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jpba.2024.116424_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2018.08.020","article-title":"Intracerebroventricular injection of histamine induces the hypothalamic-pituitary-gonadal axis activation in male rats","volume":"1699","author":"Niaz","year":"2018","journal-title":"Brain Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:47:23Z","timestamp":1778543243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524004643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"alternative-id":["S0731708524004643"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116424","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of early remission after infliximab in Crohn\u2019s disease using baseline microbiome and metabolomics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116424"}}